BI
NRXP icon

Bulldog Investors’s NRX Pharmaceuticals NRXP Stock Holding History

Bulldog Investors’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,345
Closed -$2.73M – 172
2019
Q1 		$2.73M Buy
26,345
+2,622
+11% +$269K 1.21% 26
2018
Q4 		$2.41M Sell
23,723
-4,800
-17% -$485K 0.9% 35
2018
Q3 		$2.85M Buy
28,523
+3,956
+16% +$394K 0.8% 42
2018
Q2 		$2.44M Sell
24,567
-584
-2% -$57.6K 0.64% 48
2018
Q1 		$2.46M Buy
+25,151
New +$2.45M 0.67% 43

Other funds holding NRXP

MSU
Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Bulldog Investors's NRXP Position: Q2 2019 in Review

Bulldog Investors sold out of NRX Pharmaceuticals (NRXP) in Q2 2019, closing a stake of 26,345 shares — an estimated $2.73M sold.

Bulldog Investors first reported a position in NRXP in Q1 2018 and held it in 5 quarters. The position peaked at $2.85M in Q3 2018. 17 funds tracked by Wall St. Rank hold NRXP as of Q2 2019.

  • Bulldog Investors reported no remaining NRX Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Bulldog Investors sold 26,345 NRX Pharmaceuticals shares in Q2 2019, an estimated $2.73M.
  • Bulldog Investors first reported a position in NRX Pharmaceuticals in Q1 2018 and held it in 5 quarters.
  • Bulldog Investors's NRX Pharmaceuticals position peaked at $2.85M in Q3 2018.
  • 17 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2019.

Based on Bulldog Investors's 13F filing for Q2 2019, filed 14 Aug 2019.